7-Methylxanthine Inhibits the Formation of Monosodium Urate Crystals by Increasing Its Solubility
Biomolecules · 2023
DOI: 10.3390/biom13121769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Antonia Costa-Bauza und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Renal Lithiasis Research, University Institute of Health Science Research (IUNICS-IdISBa), University of Balearic Islands, Ctra. de Val…. Hauptthemen laut MEDLINE: Uric Acid, Theobromine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación.
Abstract (Originalsprache)
Gout is characterized by the formation of monosodium urate crystals in peripheral joints. We carried out laboratory studies to investigate the effect of adding nine different methylxanthines and two different methylated uric acid derivatives on the development of these crystals over the course of 96 h in a medium whose composition was similar to that of synovial fluid. Our results showed that 7-methylxanthine reduced or totally prevented crystal formation; 1-methylxanthine, 3-methylxanthine, 7-methyluric acid, and 1,3-dimethyluric acid had weaker effects, and the other molecules had no apparent effect. The presented results indicate that a 7-methylxanthine concentration of about 6 × 10−5 M (10 mg/L) prevented the formation of crystals for an initial urate concentration of 1.78 × 10−3 M (300 mg/L) in the presence of 0.4 M of Na+ for 96 h at 25 °C and a pH of 7.4. We attribute these results to alterations in thermodynamics, not kinetics. Our results suggest that prevention of crystallization in vivo could be achieved by direct oral administration of 7-methylxanthine or other methylxanthines that are metabolized to 7-methylxanthine. For example, the hepatic metabolism of theobromine leads to significant plasma levels of 7-methylxanthine (14% of the initial theobromine concentration) and 3-methylxanthine (6% of the initial theobromine concentration); however, 7-methyluric acid is present at very low concentrations in the plasma. It is important to consider that several of the specific molecules we examined (theobromine, caffeine, theophylline, dyphylline, etophylline, and pentoxifylline) did not directly affect crystallization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Renal Lithiasis Research, University Institute of Health Science Research (IUNICS-IdISBa), University of Balearic Islands, Ctra. de Valldemossa km 7.5, 07122 Palma, Spain.
ORCID-Profile: Antonia Costa-Bauza, Felix Grases
Förderung
- Ministerio de Ciencia e Innovación
- Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación
Zitieren
APA
Costa-Bauza, A., & Grases, F. (2023). 7-Methylxanthine Inhibits the Formation of Monosodium Urate Crystals by Increasing Its Solubility. Biomolecules. https://doi.org/10.3390/biom13121769
Vancouver
Costa-Bauza A, Grases F. 7-Methylxanthine Inhibits the Formation of Monosodium Urate Crystals by Increasing Its Solubility. Biomolecules. 2023. doi:10.3390/biom13121769
BibTeX
@article{CostaBauza2023,
author = {Costa-Bauza, Antonia and Grases, Felix},
title = {7-Methylxanthine Inhibits the Formation of Monosodium Urate Crystals by Increasing Its Solubility},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13121769}
}
EUVIMED